Masimo Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Public

  • Employees
  • 3,796

Employees

  • Stock Symbol
  • MASI

Stock Symbol

  • Investments
  • 15

  • Share Price
  • $165.57
  • (As of Monday Closing)

Masimo General Information

Description

Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

Contact Information

Website
www.masimo.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 52 Discovery
  • Irvine, CA 92618
  • United States
+1 (949)
Primary Industry
Monitoring Equipment
Other Industries
Therapeutic Devices
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 52 Discovery
  • Irvine, CA 92618
  • United States
+1 (949)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Masimo Stock Performance

As of 13-Jan-2025, Masimo’s stock price is $165.57. Its current market cap is $8.91B with 53.5M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$165.57 $166.42 $101.61 - $180.97 $8.91B 53.5M 545K $1.48

Masimo Financials Summary

As of 30-Sep-2024, Masimo has a trailing 12-month revenue of $2.04B.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 7,863,070 7,068,524 8,595,642 15,549,070
Revenue 2,042,600 2,048,100 2,035,800 1,239,200
EBITDA 242,400 253,000 353,400 309,900
Net Income 78,600 81,500 143,500 229,600
Total Assets 3,087,800 3,041,500 3,210,600 1,887,000
Total Debt 860,900 970,000 1,028,800 32,700
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Masimo Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Masimo‘s full profile, request access.

Request a free trial

Masimo Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Masimo‘s full profile, request access.

Request a free trial

Masimo Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare
Monitoring Equipment
Irvine, CA
3,796 As of 2023

San Francisco, CA
 

Irvine, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Masimo Competitors (12)

One of Masimo’s 12 competitors is iRhythm Technologies, a Formerly VC-backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
iRhythm Technologies Formerly VC-backed San Francisco, CA
Edwards Lifesciences Corporation Irvine, CA
Philips Corporation Amsterdam, Netherlands
Nihon Kohden Corporation Tokyo, Japan
Drägerwerk Corporation Lubeck, Germany
You’re viewing 5 of 12 competitors. Get the full list »

Masimo Patents

Masimo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240404549-A1 Auditory health monitoring system with auricular device and physiological sensor Pending 02-Jun-2023
US-20240380246-A1 Induction charger Pending 10-May-2023
US-20240380247-A1 Induction charger Pending 10-May-2023
US-20240324953-A1 Opioid overdose detection using pattern recognition Pending 03-Apr-2023
US-20240298920-A1 Systems and methods for monitoring respiratory gases Pending 08-Mar-2023 A61B5/082
To view Masimo’s complete patent history, request access »

Masimo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Masimo Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Masimo‘s full profile, request access.

Request a free trial

Masimo Investments & Acquisitions (15)

Masimo’s most recent deal was a Merger/Acquisition with Nura. The deal was made on 06-Apr-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nura 06-Apr-2023 Merger/Acquisition Electronics (B2C)
Sound United 11-Apr-2022 Merger/Acquisition Electronics (B2C)
NeurAxis 29-Mar-2021 Later Stage VC Therapeutic Devices
LiDCO Group 01-Dec-2020 Merger/Acquisition Therapeutic Devices
TNI Medical 28-Mar-2020 Merger/Acquisition Therapeutic Devices
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Masimo ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

31.28 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,104

Rank

Percentile

Healthcare

Industry

of 588

Rank

Percentile

Medical Devices

Subindustry

of 200

Rank

Percentile

To view Masimo’s complete esg history, request access »

Masimo Exits (1)

Masimo’s most recent exit was on 29-Mar-2021 from NeurAxis. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
NeurAxis 29-Mar-2021 Completed
  • 2 buyers
To view Masimo’s complete exits history, request access »

Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Nura Brunswick, Australia 2015
TNI Medical Wurzburg, Germany 2007
Masimo (Audio And Consumer Health Businesses) Irvine, CA
Masimo Semiconductor Hudson, NH

Masimo FAQs

  • When was Masimo founded?

    Masimo was founded in 1989.

  • Where is Masimo headquartered?

    Masimo is headquartered in Irvine, CA.

  • What is the size of Masimo?

    Masimo has 3,796 total employees.

  • What industry is Masimo in?

    Masimo’s primary industry is Monitoring Equipment.

  • Is Masimo a private or public company?

    Masimo is a Public company.

  • What is Masimo’s stock symbol?

    The ticker symbol for Masimo is MASI.

  • What is the current stock price of Masimo?

    As of 13-Jan-2025 the stock price of Masimo is $165.57.

  • What is the current market cap of Masimo?

    The current market capitalization of Masimo is $8.91B.

  • What is Masimo’s current revenue?

    The trailing twelve month revenue for Masimo is $2.04B.

  • Who are Masimo’s competitors?

    iRhythm Technologies, Edwards Lifesciences, Philips, Nihon Kohden, and Drägerwerk are some of the 12 competitors of Masimo.

  • What is Masimo’s annual earnings per share (EPS)?

    Masimo’s EPS for 12 months was $1.48.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »